Skip to main content

Table 1 Population clinical and laboratory characteristics based on MetS presence

From: Diversity of Apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of Metabolic Syndrome among hypertensive patients

 

Total

MetS (+)

MetS (−)

p

(n = 266)

(n = 117)

Men

184 (48.0%)

117 (43.9%)

67 (57.2%)

< 0.05

Age (years)

64.0 ± 12.0

64.0 ± 11.7

63.7 ± 12.7

NS

White

244 (63.7%)

173 (65%)

71 (60.6%)

NS

Weight (kg)

78.0 ± 44.4

82.1 ± 52.2

69.0 ± 13.7

< 0.05

BMI (kg/cm2)

29.3 ± 5.6

30.6 ± 5.2

26.5 ± 5.6

< 0.05

Waist (cm)

100.2 ± 13.8

104.5 ± 11.8

90.8 ± 13.1

< 0.05

DM

173 (45.1%)

144 (54.1%)

29 (24.7%)

< 0.05

Dislipidemia

311 (81.2%)

229 (86%)

82 (70%)

< 0.05

CVD

133 (34.7%)

101 (37.9%)

32 (27.3%)

< 0.05

Sedentarism

302 (78.8%)

210 (78.9%)

92 (78.6%)

NS

Smoking

45 (11.7%)

34 (12.7%)

11 (9.4%)

NS

Alcohol

28 (7.3%)

18 (6.7%)

10 (8.5%)

NS

Chol (mg/dl)

181.5 ± 40.0

181.5 ± 41.8

181.9 ± 36.2

NS

HDL-c (mg/dl)

46.6 ± 13.0

42.6 ± 9.9

55.7 ± 14.9

< 0.05

LDL-c (mg/dl)

105.0 ± 33.5

105.0 ± 35.1

105.4 ± 30.0

NS

TG (mg/dl)

151.2 ± 83.8

170.3 ± 83.7

109.7 ± 68.7

< 0.05

Cr (mg/dl)

1.46 ± 0,86

1.46 ± 0.89

1.44 ± 0,83

NS

U (mg/dl)

58.7 ± 31.3

58.9 ± 31.7

58.5 ± 31,0

NS

CRP (mg/dl)

0.56 ± 0.77

0.64 ± 0.86

0.39 ± 0.51

< 0.05

  1. BMI: body max index; DM: diabetes mellitus; Chol: total cholesterol; HDL-C: HDL cholesterol; LDL-c: LDL cholesterol; TG: triglycerides; Cr: creatinine; U: urea; CRP: C reactive protein. p: <0,05 MetS (+) versus Mets (−); p: NS, non significant.